BR0012694A - Conjugado de protease, composição de limpeza e composição de tratamento pessoal - Google Patents

Conjugado de protease, composição de limpeza e composição de tratamento pessoal

Info

Publication number
BR0012694A
BR0012694A BR0012694-2A BR0012694A BR0012694A BR 0012694 A BR0012694 A BR 0012694A BR 0012694 A BR0012694 A BR 0012694A BR 0012694 A BR0012694 A BR 0012694A
Authority
BR
Brazil
Prior art keywords
protease
composition
cleaning
personal treatment
conjugates
Prior art date
Application number
BR0012694-2A
Other languages
English (en)
Inventor
David John Weisgerber
Donn Nelton Rubingh
Paul Elliott Correa
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0012694A publication Critical patent/BR0012694A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38609—Protease or amylase in solid compositions only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)

Abstract

"CONJUGADO DE PROTéASE, COMPOSIçãO DE LIMPEZA E COMPOSIçãO DE TRATAMENTO PESSOAL". A presente exposição relaciona-se com conjugados de protéase de subtilisina que compreendem uma metade de protéase e uma ou mais metades de adição. Cada metade de adição é fixada covalentemente a uma posição de proteção de local de corte da metade de protéase, em que as posições de proteção de local de corte são selecionadas a partir de 13, 14, 15, 16, 18, 19, 20, 21, 84, 85, 88, 158, 159, 160, 161, 162, 163, 164, 165, 170, 186, 191, 192, 193, 194, 196, 259, 260, 261, 262, e 274 correspondentes à subtilisina BPN'. Os conjugados de protéase são dotados de imunogenicidade diminuída em relação a uma protéase de origem. A presente exposição relaciona-se ainda com composições de limpeza e de tratamento pessoal que compreendem os conjugados de protéase.
BR0012694-2A 1999-07-22 2000-07-11 Conjugado de protease, composição de limpeza e composição de tratamento pessoal BR0012694A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14498199P 1999-07-22 1999-07-22
PCT/US2000/018855 WO2001007484A2 (en) 1999-07-22 2000-07-11 Protease conjugates having sterically protected clip sites

Publications (1)

Publication Number Publication Date
BR0012694A true BR0012694A (pt) 2002-04-09

Family

ID=22511058

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012694-2A BR0012694A (pt) 1999-07-22 2000-07-11 Conjugado de protease, composição de limpeza e composição de tratamento pessoal

Country Status (11)

Country Link
US (1) US6566115B1 (pt)
EP (1) EP1196548A2 (pt)
JP (1) JP2003516116A (pt)
KR (1) KR20020021395A (pt)
CN (1) CN1377406A (pt)
AU (1) AU5928400A (pt)
BR (1) BR0012694A (pt)
CA (1) CA2379729A1 (pt)
CZ (1) CZ2002171A3 (pt)
MX (1) MXPA02000842A (pt)
WO (1) WO2001007484A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062380A2 (en) * 2002-01-16 2003-07-31 Genencor International, Inc. Multiply-substituted protease variants
US7888093B2 (en) 2002-11-06 2011-02-15 Novozymes A/S Subtilase variants
JP4490290B2 (ja) * 2002-12-31 2010-06-23 ネクター セラピューティクス アラバマ，コーポレイション 加水分解安定性マレイミド末端ポリマー
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
GB0416155D0 (en) * 2004-07-20 2004-08-18 Unilever Plc Laundry product
GB0423986D0 (en) * 2004-10-29 2004-12-01 Unilever Plc Method of preparing a laundry product
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
GB0610801D0 (en) 2006-05-31 2006-07-12 Unilever Plc Laundry product
US9828597B2 (en) 2006-11-22 2017-11-28 Toyota Motor Engineering & Manufacturing North America, Inc. Biofunctional materials
JP2014091815A (ja) * 2012-11-06 2014-05-19 Kao Corp 洗浄剤組成物
JP2017149952A (ja) * 2017-02-28 2017-08-31 花王株式会社 洗浄剤組成物
CN119932005B (zh) * 2025-04-08 2025-12-12 天津凯莱英生物科技有限公司 固定化酶、其制备方法和应用

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795238A (fr) 1972-02-09 1973-08-09 Schering Ag Derives d'insuline reticules de maniere intramoleculaire, leur procede de preparation et leur utilisation
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE2631656C2 (de) 1976-07-14 1983-02-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung eines Hydroxysuccinimidoester-Derivats zur Bindung von biologisch aktiven Proteinen aneinander und/oder an flüssige oder feste Trägerstoffe
HU182981B (en) 1978-07-04 1984-03-28 Novo Industri As Process for producing protease consentrate
US4556554A (en) 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
NZ208612A (en) 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US4732863A (en) 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
US4844897A (en) * 1985-09-13 1989-07-04 Hiroshi Maeda Anti-tumor protease preparations
WO1987004461A1 (en) 1986-01-15 1987-07-30 Amgen THERMALLY STABLE AND pH STABLE SUBTILISIN ANALOGS AND METHOD FOR PRODUCTION THEREOF
US4980288A (en) 1986-02-12 1990-12-25 Genex Corporation Subtilisin with increased thermal stability
WO1987005050A1 (en) 1986-02-12 1987-08-27 Genex Corporation Mutagenesis and screening method and product
US4908773A (en) 1987-04-06 1990-03-13 Genex Corporation Computer designed stabilized proteins and method for producing same
DE3750916T2 (de) 1986-04-30 1995-06-01 Genencor Int Mutante einer nicht menschlichen Carbonyl-Hydrolase, für diese kodierende DNS-Sequenzen und Vektoren und durch diese Vektoren transformierte Wirte.
NZ221627A (en) 1986-09-09 1993-04-28 Genencor Inc Preparation of enzymes, modifications, catalytic triads to alter ratios or transesterification/hydrolysis ratios
WO1988007578A1 (en) 1987-04-02 1988-10-06 Genentech, Inc. Substrate assisted catalysis
WO1988008028A1 (en) 1987-04-06 1988-10-20 Genex Corporation The engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins
US4853871A (en) 1987-04-06 1989-08-01 Genex Corporation Computer-based method for designing stablized proteins
US4914031A (en) 1987-04-10 1990-04-03 Amgen, Inc. Subtilisin analogs
US5543302A (en) * 1988-05-27 1996-08-06 Solvay Enzymes, Inc. Proteases of altered stability to autolytic degradation
JPH02219571A (ja) * 1989-02-20 1990-09-03 Kanebo Ltd 修飾プロテアーゼ及びその製造法
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
KR100188532B1 (ko) 1989-05-17 1999-06-01 스티븐 엠. 오드리 돌연변이 섭티리신 및 그를 함유하는 조성물
ES2227508T3 (es) 1989-06-26 2005-04-01 Unilever N.V. Composiciones detergentes enzimaticas.
US5658871A (en) 1989-07-07 1997-08-19 Lever Brothers Company, Division Of Conopco, Inc. Microbial lipase muteins and detergent compositions comprising same
US5352603A (en) * 1989-08-31 1994-10-04 Kali-Chemie Ag Highly alkaline proteases
DK97190D0 (da) 1990-04-19 1990-04-19 Novo Nordisk As Oxidationsstabile detergentenzymer
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US5230891A (en) 1990-08-20 1993-07-27 Kanebo Limited Modified protease, method of producing the same and cosmetic products containing the modified protease
US5133968A (en) 1990-08-20 1992-07-28 Kanebo, Ltd. Modified protease, method of producing the same and cosmetic products containing the modified protease
US5766898A (en) 1990-12-05 1998-06-16 Novo Nordisk A/S Proteins with changed epitopes and methods for the production thereof
CA2095852C (en) 1990-12-05 2001-05-08 Uffe Lovborg Proteins with changed epitopes and methods for the production thereof
ES2090481T3 (es) 1991-05-01 1996-10-16 Unilever Nv Composiciones detergentes que contienen enzimas estabilizadas.
US5340735A (en) * 1991-05-29 1994-08-23 Cognis, Inc. Bacillus lentus alkaline protease variants with increased stability
US5414135A (en) 1991-12-30 1995-05-09 Sterling Winthrop Inc. Vinyl sulfone coupling of polyoxyalkylenes to proteins
IT1260468B (it) 1992-01-29 1996-04-09 Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
GB9207280D0 (en) 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition
GB9207288D0 (en) 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
ES2290976T3 (es) 1992-06-05 2008-02-16 The Scripps Research Institute D-proteina ligada y metodo para identificar compuestos que modulan la actividad de receptores.
WO1994004193A1 (en) 1992-08-21 1994-03-03 Enzon, Inc. Novel attachment of polyalkylene oxides to bio-effecting substances
CA2101361A1 (en) 1992-08-27 1994-02-28 Robert A. Snow Low diol polyalkylene oxide biologically active proteinaceous substances
US5567601A (en) 1993-06-01 1996-10-22 University Of Maryland Subtilisin mutants lacking a primary calcium binding site
US6436690B1 (en) 1993-09-15 2002-08-20 The Procter & Gamble Company BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
BR9407502A (pt) 1993-09-15 1997-01-07 Procter & Gamble Variantes subtilisina bpn com adsorção diminuída e hidrólise aumentada
MA23346A1 (fr) 1993-10-14 1995-04-01 Genencor Int Variantes de la subtilisine
US6187579B1 (en) 1993-10-28 2001-02-13 Carlsberg A/S Customized proteases
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
ZA952220B (en) 1994-05-02 1995-12-14 Procter & Gamble Bpn' variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
US5629384A (en) 1994-05-17 1997-05-13 Consiglio Nazionale Delle Ricerche Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
AU3924095A (en) 1994-11-24 1996-06-17 Novo Nordisk A/S A process for producing polypeptides with reduced allergenicity
AU697440B2 (en) 1994-12-07 1998-10-08 Novozymes A/S Polypeptide with reduced allergenicity
ATE257844T1 (de) 1995-03-10 2004-01-15 Nakamura Toshikazu Menschlicher wachstumsfaktor (hgf), verändert durch polyethylenglykol
AU5893696A (en) 1995-06-07 1996-12-30 Novo Nordisk A/S Modification of polypeptides
AU5893796A (en) 1995-06-07 1996-12-30 Novo Nordisk A/S Modification of polypeptides
DE19530816A1 (de) 1995-08-23 1997-02-27 Cognis Bio Umwelt Verwendung von mutierter Subtilisin-Protease in kosmetischen Produkten
CA2241593A1 (en) 1995-12-29 1997-07-10 The Procter & Gamble Company Detergent compositions comprising immobilized enzymes
WO1997024421A2 (en) 1995-12-29 1997-07-10 The Procter & Gamble Company Detergent compositions comprising immobilized enzymes
CN1273589C (zh) 1996-02-15 2006-09-06 诺沃奇梅兹有限公司 多肽缀合
US6946280B1 (en) 1996-03-29 2005-09-20 Genencor International, Inc. Enzyme multimer and process of producing same
US6060546A (en) * 1996-09-05 2000-05-09 General Electric Company Non-aqueous silicone emulsions
CN1530443A (zh) * 1996-11-04 2004-09-22 ŵ����÷�����޹�˾ 枯草杆菌酶变异体和组合物
CA2273079C (en) * 1996-11-26 2012-04-10 Genencor International, Inc. Chemically modified subtilisin mutants
JP2002510963A (ja) 1997-01-10 2002-04-09 ノボザイムス アクティーゼルスカブ スキンケア用酵素修飾体
JP2001511162A (ja) 1997-02-06 2001-08-07 ノボ ノルディスク アクティーゼルスカブ 付加され、そして／又は除去された付着基を有するポリペプチド−ポリマー結合体
WO1999000489A1 (en) * 1997-06-25 1999-01-07 Novo Nordisk A/S A modified polypeptide
AR016969A1 (es) * 1997-10-23 2001-08-01 Procter & Gamble VARIANTE DE PROTEASA, ADN, VECTOR DE EXPRESIoN, MICROORGANISMO HUESPED, COMPOSICIoN DE LIMPIEZA, ALIMENTO PARA ANIMALES Y COMPOSICIoN PARA TRATAR UN TEXTIL
US5972339A (en) 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
GB9727262D0 (en) 1997-12-24 1998-02-25 Smithkline Beecham Biolog Vaccine
KR20010040397A (ko) 1998-01-23 2001-05-15 마가렛 에이.혼 개질된 효소 및 펩티드 합성에 이들을 사용하는 용도
CA2320960A1 (en) 1998-02-11 1999-08-19 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
EP1053015A2 (en) 1998-02-12 2000-11-22 American Cyanamid Company Pneumococcal and meningococcal vaccines formulated with interleukin-12
WO1999042098A1 (en) 1998-02-24 1999-08-26 Dovetail Technologies Inc. Small molecules that increase the conversion of food to body weight gain
AU747917B2 (en) 1998-03-05 2002-05-30 Medical College Of Ohio, The Enhancement of immunity by intranasal inoculation of IL-12
US5985264A (en) 1998-03-05 1999-11-16 The Medical College Of Ohio IL-12 Stimulation of Neonatal immunity
US6328967B1 (en) 1998-03-12 2001-12-11 Allergenics, Inc. Delivery system to modulate immune response
BR9909130A (pt) 1998-03-26 2000-12-19 Procter & Gamble Variantes de protease de serina tendo substituições de amino-ácido
US6495136B1 (en) 1998-03-26 2002-12-17 The Procter & Gamble Company Proteases having modified amino acid sequences conjugated to addition moieties
WO2000009707A1 (en) 1998-06-24 2000-02-24 Genencor International, Inc. Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same
AU772427B2 (en) 1998-11-10 2004-04-29 Genencor International, Inc. Chemically modified mutant serine hydrolases show improved catalytic activity and chiral selectivity
DE69941223D1 (de) * 1998-12-21 2009-09-17 Billig Fritz Chemisch modifizierte enzymen mit mehrfachgeladenen varianten
US7881935B2 (en) 2000-02-28 2011-02-01 Sony Corporation Speech recognition device and speech recognition method and recording medium utilizing preliminary word selection

Also Published As

Publication number Publication date
CA2379729A1 (en) 2001-02-01
MXPA02000842A (es) 2002-07-30
WO2001007484A2 (en) 2001-02-01
AU5928400A (en) 2001-02-13
EP1196548A2 (en) 2002-04-17
KR20020021395A (ko) 2002-03-20
CZ2002171A3 (cs) 2002-06-12
WO2001007484A3 (en) 2001-06-07
US6566115B1 (en) 2003-05-20
JP2003516116A (ja) 2003-05-13
CN1377406A (zh) 2002-10-30

Similar Documents

Publication Publication Date Title
BR9909129A (pt) Conjugados de proteases
BR0010704A (pt) Composições e métodos de anti-náusea
BR0203273A (pt) Composições detergentes umedecedoras
TR200103469T2 (tr) Amiloidojenik hastalığının önlenmesi ve tedavisi
PT1200105E (pt) Factor viii modificado
ATE195721T1 (de) Lipopolyamine als transfectionsmittel und ihre pharmazeutischen anwendungen
EP1423107A4 (en) FATTY ALCOHOL DRUG CONJUGATES
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
FR2746101B1 (fr) Composes bicycliques-aromatiques
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
FR2746098B1 (fr) Composes propynyl biaromatiques
BR9507437A (pt) Base livre de halofantrina e composições para o tratamento da malária
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
PT1007040E (pt) Utilizacao de fanquinona no tratamento da doenca de alzheimer
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
EE200100125A (et) TAN-1057 derivaadid
BR0012692A (pt) Conjugado de protease, composição de limpeza e composição de tratamento pessoal
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
DK0977871T3 (da) Neurotrypsin
WO2001007484A3 (en) Protease conjugates having sterically protected clip sites
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
DE60204967D1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
BR0113623A (pt) Proteìnas sintéticas de estìmulo da eritropoiese
DE60003074D1 (de) Fusidinsäure-derivate

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.